Biotech Values

[jmkobers]

Unrealistic expectations(40, 60, 80/pps post approval) lead to disappointment, and eventually people start bailing. I think the consensus was that the huge dump to ~15 was a temporary thing(well supported theory here, obviously) and it could be setting in that it isn't. What could propel this stock forward aggressively in the next year? Not much besides a possible partner and I am not sure how much that would move it. Copaxone is probably years away(best case).

As Wallstarb said the the cash is nice but it won't move the price much unless it goes on for 2+ years. People should have listened to him and not Dew. They would have been much better off.